Herein, we planned to systematically appraise the clinicopathological significance and explore the molecular bases of CKS2 in endometrial carcinoma using multiple detection technologies, including microarrays, RNA-seq, and in-house tissue microarrays. Here, CKS2 is linked to endometrial carcinoma.